In their study, the positive correlation of PD-L1 expression and mutations associated with non-GCB DLBCL such as FAT2 contrasted with the negative correlation of mutations associated with GCB DLBCL such as BCL2, FOXO1 and KMT2D. Here, FAT2 is linked to diffuse large B-cell lymphoma.